PSÖRİYAZİSLİ HASTALARDA VE SAĞLIKLI KONTROLLERDE FONKSİYONEL EGZERSİZ KAPASİTESİ, PERİFERİK KAS KUVVETİ, NEFES DARLIĞI VE YAŞAM KALİTESİNİN KARŞILAŞTIRILMASI: KESİTSEL BİR ÇALIŞMA

Abstract

Amaç: Bu çalışma psöriyazisli hastalar ve sağlıklı bireylerde fonksiyonel egzersiz kapasitesi, üst ve alt ekstremite kas kuvveti, dispne, yorgunluk, yaşam kalitesi (YK), fiziksel aktivite (FA) düzeyi ve kardiyovasküler hastalıklar bilgi düzeyinin karşılaştırılmasını amaçladı. Yöntem: Çalışmaya 36 hasta ve 36 sağlıklı kontrol dâhil edildi. Bireylerin fonksiyonel egzersiz kapasitesi [6 dakika yürüme testi (6-DYT)], üst ve alt ekstremite kas kuvveti (Dinamometre), dispne [Modifiye Medikal Araştırma Kurulu Ölçeği (MMRC)], yorgunluk [Yorgunluk Şiddet Ölçeği (YŞÖ)], YK [Kısa Form 36 anketi (SF-36)], FA seviyesi [Uluslararası Fiziksel Aktivite Anketi (UFAA)], kardiyovasküler hastalıklar bilgi düzeyi [Kardiyovasküler Hastalıklar Risk Faktörleri Bilgi Düzeyi Ölçeği (KARRİF-BD)] ve hastalık şiddeti [Psoriasis Alan Şiddet İndeksi (PAŞİ)] değerlendirildi. Bulgular: Hasta [49(38.50-58) yıl, 16E/20K] ve sağlıklı kontrollerin [51(46.25-55) y, 23E/13K] demografik özellikleri benzerdi (p>0,05). Hastalarda 6-DYT mesafesi, üst ve alt ekstremite kas kuvveti, SF-36 alt ölçek, UFAA, ve KARRİF-BD puanları kontrollere göre anlamlı olarak daha düşük; YŞÖ ve MMRC skorları daha yüksekti (p<0,05). Sonuç: Psöriasisli hastaların, sağlıklı kontrollere göre fonksiyonel egzersiz kapasitesi, üst ve alt ekstremite kas kuvveti azalmış, yorgunluk ve nefes darlığı algısı artmış, FA düzeyi, YK ve kardiyovasküler hastalıklar bilgi düzeyi azalmıştı. Psöriasisli hastalar kardiyak rehabilitasyon programlarına yönlendirilmelidir.

Keywords

• Psöriyazis
• Egzersiz Testi
• Kas Gücü
• Nefes Darlığı
• Fiziksel Aktivite

COMPARISON OF FUNCTIONAL EXERCISE CAPACITY, PERIPHERAL MUSCLE STRENGTH, DYSPNEA AND QUALITY OF LIFE IN PATIENTS WITH PSORIASIS AND HEALTHY CONTROLS: A CROSS-SECTIONAL STUDY

Abstract

Objective: This study was aimed to compare the functional exercise capacity, upper and lower extremity muscle strength, dyspnea, fatigue, quality of life (QoL), level of physical activity (PA), and cardiovascular diseases knowledge level in patients with psoriasis and healthy individuals. Method: Thirty-six patients and 36 healthy controls were included in the study. The functional exercise capacity [6 minutes walking test (6-MWT)], upper and lower extremity muscle strength (Dynamometer), dyspnea severity [Modified Medical Research Council Dyspnea scale (MMRC)], fatigue severity [Fatigue Severity Scale (FSS)], QoL [The Short Form 36 questionnaire (SF-36)], PA [The International Physical Activity Questionnaire (IPAQ)], cardiovascular diseases knowledge level [Risk Factors in Cardiovascular Disease Knowledge Level (CARRF-KL)scale], and disease severity [Psoriasis Area and Severity Index (PASI)] of the individuals were evaluated. Results: Demographic characteristics were similar in patients [49(38.50-58) years, 16M/20F] and healthy controls [51(46.25-55) y, 23M/13F] (p>0.05). The 6-MWT distance, upper and lower extremity muscle strength, SF-36 subscales, IPAQ, and CARRF-KL scores were significantly lower; FSS and MMRC scores were higher in patients than controls (p<0.05). Conclusion: Patients with psoriasis had decreased functional exercise capacity, upper and lower extremity muscle strength, increased perception of fatigue and dyspnea, reduced PA level, QoL, and cardiovascular diseases knowledge level compared with healthy controls. Patients with psoriasis should be directed to cardiac rehabilitation programs.

Keywords

• Psoriasis
• Exercise Test
• Muscle Strength
• Dyspnea
• Physical Activity

References

1. Lopes N, Dias LLS, Azulay-Abulafia L, et al. Humanistic and economic impact of moderate to severe plaque psoriasis in Brazil. Adv Ther. 2019;36(10):2849-2865.
2. Kamiya K, Kishimoto M, Sugai J, et al. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20(18):4347.
3. Wilson PB. Cardiorespiratory Fitness Among Individuals With Psoriasis in the General Population. J Phys Act Health. 2016;13(7):771-775.
4. Wilson PB, Bohjanen KA, Ingraham SJ, Leon AS. Psoriasis and physical activity: a review. J Eur Acad Dermatol Venereol. 2012;26:1345-1353.
5. Proietti I, Raimondi G, Skroza N, et al. Cardiovascular risk in psoriatic patients detected by heart rate variability (HRV) analysis. Drug Dev Res. 2014;75:S81-S84.
6. Tuttle CSL, Thang LAN, Maier AB. Markers of inflammation and their association with muscle strength and mass: a systematic review and meta-analysis. Ageing Res Rev. 2020;64:101185.
7. Ng CY, Yang YW, Liu SH, et al. SF-36 healty survey on psoriasis quality-of-life: a study of 414 Taiwanese patients. J Dermatol. 2015;42(2):159-165.
8. Deniz F, Kivanc Altunay I, Ozkur E, et al. Evaluation of healthy lifestyle behaviors in psoriasis patients. Med Bull Sisli Etfal Hosp. 2021;55(2):197-202.

9. Torres T, Alexandre JM, Mendonça D, et al. Levels of physical activity in patients with severe psoriasis: a cross-sectional questionnaire study. Am J Clin Dermatol. 2014;15(2):129-135.
10. Rosen J, Landriscina A, Friedman AJ. Psoriasis-associated fatigue: pathogenesis, metrics, and treatment. Cutis. 2016;97(2):125-132.
11. Auker L, Cordingley L, Pye SR, et al. What are the barriers to physical activity in patients with chronic plaque psoriasis?. Br J Dermatol. 2020;183(6):1094-1102.
12. Ishikawa G, Dua S, Mathur A, et al. Concomitant interstitial lung disease with psoriasis. Can Respir J. 2019;2019:5919304.
13. Wahl AK, Moum T, Robinson HS, et al. Psoriasis patients' knowledge about the disease and treatments. Dermatol Res Pract. 2013;2013:921737.
14. ATS committee on proficiency standards for clinical pulmonary function laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117.
15. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14:270-274.
16. Chuang ML, Lin IF, Wasserman K. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients. Respir Med. 2001;95:618-626.
17. Bohannon RW. Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil. 1997;78(1):26-32.
18. Schmidt RT, Toews JV. Grip strength as measured by the Jamar dynamometer. Arch Phys Med Rehabil. 1970;51(6):321-327.
19. Armutlu K, Korkmaz NC, Keser I, et al. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res. 2007;30(1):81-85.
20. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580-586.
21. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
22. Saglam M, Arikan H, Savci S, et al. International Physical Activity Questionnaire: reliability and validity of the Turkish version. Percept Mot Skills. 2010;111(1):278-284.
23. Kocyigit H, Aydemir O, Fisek G, et al. Validity and reliability of Turkish version of Short form 36: a study of a patients with rheumatoid disorder. Journal of Drug and Therapy. 1999;12:102-106.
24. Arikan I, Metintaş S, Kalyoncu C, et al. The Cardiovascular Disease Risk Factors Knowledge Level (CARRF-KL) Scale: a validity and reliability study. Turk Kardiyol Dern Ars. 2009;37(1):35-40.
25. Berth-Jones J, Grotzinger K, Rainville C, et al. A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: psoriasis area and severity index, physician’s global assessment and lattice system physician’s global assessment. Br J Dermatol. 2006;155:707-713.
26. Skoie IM, Dalen I, Ternowitz T, et al. Fatigue in psoriasis: a controlled study. Br J Dermatol. 2017;177(2):505-512.
27. Demirel R, Genc A, Ucok K, et al. Do patients with mild to moderate psoriasis really have a sedentary lifestyle? Int J Dermatol. 2013;52(9):1129-1134.
28. Candiri B, Talu B, Demirtas Karaoba D, et al. Effect of psoriatic arthritis on the strength, proprioception, skill, coordination, and functional condition of the hand. Int J Rheum Dis. 2022;25(1):47-55.
29. Fukushi I, Pokorski M, Okada Y. Mechanisms underlying the sensation of dyspnea. Respir Investig. 2021;59(1):66-80.
30. Li Z, Zhao H, Wang J. Metabolism and chronic inflammation: the links between chronic heart failure and comorbidities. Front Cardiovasc Med. 2021;8:650278.
31. Ungprasert P, Srivali N, Thongprayoon C. Association between psoriasis and chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Dermatolog Treat. 2016;27:316-321.
32. Amin M, Lee EB, Bhutani T, et al. Do psoriasis patients engage in vigorous physical activity? Cutis. 2018;101(3):198-200.
33. Jankovic S, Raznatovic M, Marinkovic J, et al. Health-related quality of life in patients with psoriasis. J Cutan Med Surg. 2011;15(1):29-36.